(Q33467330)

27 July 2017

title

Estimating progression rates for human papillomavirus infection from epidemiological data (English)

1 reference

human papillomavirus infection

27 July 2017

1 reference

1 reference

1

Mark Jit

1 reference

27 July 2017

Nigel Gay

2

1 reference

27 July 2017

Kate Soldan

series ordinal

3

1 reference

27 July 2017

Yoon Hong Choi

series ordinal

4

1 reference

27 July 2017

William John Edmunds

series ordinal

5

1 reference

27 July 2017

publication date

12 June 2009

1 reference

27 July 2017

published in

Medical Decision Making

1 reference

27 July 2017

volume

30

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

84-98

1 reference

Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Economic evaluation of human papillomavirus vaccination in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Model for assessing human papillomavirus vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Long‐term follow‐up of patients following negative colposcopy: a new gold standard and its implications for cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Equation of State Calculations by Fast Computing Machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Modeling human papillomavirus vaccine effectiveness: quantifying the impact of parameter uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Cost-effectiveness of a potential vaccine for human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Multiparameter Calibration of a Natural History Model of Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

A 2‐Year Prospective Study of Human Papillomavirus Persistence among Women with a Cytological Diagnosis of Atypical Squamous Cells of Undetermined Significance or Low‐Grade Squamous Intraepithelial Lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0272989X09336140

21 January 2018

Identifiers

DOI

10.1177/0272989X09336140

1 reference

27 July 2017

1 reference